Correlation Between Qualigen Therapeutics and ENB Financial

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Qualigen Therapeutics and ENB Financial at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Qualigen Therapeutics and ENB Financial into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Qualigen Therapeutics and ENB Financial Corp, you can compare the effects of market volatilities on Qualigen Therapeutics and ENB Financial and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Qualigen Therapeutics with a short position of ENB Financial. Check out your portfolio center. Please also check ongoing floating volatility patterns of Qualigen Therapeutics and ENB Financial.

Diversification Opportunities for Qualigen Therapeutics and ENB Financial

-0.41
  Correlation Coefficient

Very good diversification

The 3 months correlation between Qualigen and ENB is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Qualigen Therapeutics and ENB Financial Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ENB Financial Corp and Qualigen Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Qualigen Therapeutics are associated (or correlated) with ENB Financial. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ENB Financial Corp has no effect on the direction of Qualigen Therapeutics i.e., Qualigen Therapeutics and ENB Financial go up and down completely randomly.

Pair Corralation between Qualigen Therapeutics and ENB Financial

Given the investment horizon of 90 days Qualigen Therapeutics is expected to under-perform the ENB Financial. In addition to that, Qualigen Therapeutics is 2.17 times more volatile than ENB Financial Corp. It trades about -0.13 of its total potential returns per unit of risk. ENB Financial Corp is currently generating about 0.04 per unit of volatility. If you would invest  1,709  in ENB Financial Corp on August 25, 2024 and sell it today you would earn a total of  66.00  from holding ENB Financial Corp or generate 3.86% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy95.38%
ValuesDaily Returns

Qualigen Therapeutics  vs.  ENB Financial Corp

 Performance 
       Timeline  
Qualigen Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Qualigen Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
ENB Financial Corp 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in ENB Financial Corp are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak fundamental drivers, ENB Financial may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Qualigen Therapeutics and ENB Financial Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Qualigen Therapeutics and ENB Financial

The main advantage of trading using opposite Qualigen Therapeutics and ENB Financial positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Qualigen Therapeutics position performs unexpectedly, ENB Financial can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ENB Financial will offset losses from the drop in ENB Financial's long position.
The idea behind Qualigen Therapeutics and ENB Financial Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.